AKYA - Akoya Biosciences, Inc.

QQQ $ 442.84 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.28 $ -2.45 (-1.12 %)

Previous Close

$ 4.12

Open

$ 4.41

Bid

$ 4.23 x 100

Ask

$ 0.00 x 0

Day's Range

$ 4.21 - $ 4.42

52 Week Range

$ 3.04 - $ 8.80

Volume

125,424

Average Volume

Market Cap

183.07M

Beta (5Y Monthly)

$ 1.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-04-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-07-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-07-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	03-14-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-11-2021	06-30-2021	10-Q
12	05-19-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Akoya Biosciences Cuts FY24 Revenue Foreca...
05/13/2024 20:38:26

Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow ...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

Akoya Biosciences Q1 2024 Adj EPS $(0.39) ...
05/13/2024 20:14:50

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $...

Akoya Biosciences And NeraCare Enter Exclu...
05/09/2024 13:02:28

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for ...

Akoya Biosciences And Shanghai KR Pharmtec...
05/02/2024 12:19:37

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing mol...

JP Morgan Maintains Overweight on Akoya Bi...
03/06/2024 16:06:20

JP Morgan analyst Tycho Peterson maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target fro...

UBS Maintains Buy on Akoya Biosciences, Ra...
03/05/2024 14:44:40

UBS analyst John Sourbeer maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and raises the price target from $7 to $7.5.

Canaccord Genuity Reiterates Buy on Akoya ...
03/05/2024 13:58:22

Canaccord Genuity analyst Kyle Mikson reiterates Akoya Biosciences (NASDAQ:AKYA) with a Buy and maintains $10 price target.

Akoya Biosciences Sees FY24 Revenue $114M-...
03/04/2024 21:40:32

2024 Financial OutlookThe Company, based on its current plans and initiatives, expects full year 2024 revenue guidance range of...

Recap: Akoya Biosciences Q4 Earnings
03/04/2024 21:15:10

Akoya Biosciences Q4 2023 GAAP EPS $(0.22)...
03/04/2024 21:15:05

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

Earnings Outlook For Akoya Biosciences
03/01/2024 15:01:18

Akoya Biosciences Announces Preliminary Fi...
01/07/2024 20:18:14

Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited re...

Akoya Biosciences Announced Earlier Sunday...
01/07/2024 16:06:45

Akoya Biosciences, Inc., (NASDAQ:AKYA), The Spatial Biology Company®, in collaboration with Enable Medicine, a leading provider...

Akoya Biosciences And Thermo Fisher Scient...
01/07/2024 16:05:11

Akoya Biosciences, Inc., (NASDAQ:AKYA), The Spatial Biology Company®, today announced that it has entered into a license and di...

Analyst Ratings for Akoya Biosciences
12/14/2023 14:00:39

Guggenheim Initiates Coverage On Akoya Bio...
12/14/2023 11:23:37

Guggenheim analyst Subbu Nambi initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Neutral rating.

Piper Sandler Maintains Overweight on Akoy...
11/13/2023 21:09:50

Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price targ...

Expert Ratings for Akoya Biosciences
11/13/2023 15:00:25